SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alembic Pharmaceuticals raises Rs 150 crore via NCDs

19 Mar 2019 Evaluate

Alembic Pharmaceuticals has raised Rs 150 crore through allotted of 1,500 at 8.37% Unsecured Listed Rated Redeemable Non-Convertible Debentures (NCDs) of Rs 10 lakh per NCD under Tranche III. The NCD Committee of the Company at its meeting held on March 19, 2019 has allotted the same.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

815.30 0.10 (0.01%)
03-Jul-2026 14:19 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1908.60
Dr. Reddys Labs. 1376.90
Cipla 1460.20
Zydus Lifesciences 1135.90
Lupin 2472.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: